Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion

Journal of Lipid Research

Volumn 38, Issue 9, 1997, Pages 1807-1821

  Mendez, Armando J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein A 1; Cholesteryl esters; Fibroblasts; High density lipo proteins; Phospholipid vesicles

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ACTIVE TRANSPORT; ARTICLE; CELL ENERGY; CELL GROWTH; CELL METABOLISM; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; DIFFUSION; FIBROBLAST; HUMAN; HUMAN CELL; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS; BIOLOGICAL TRANSPORT; BIOLOGICAL TRANSPORT, ACTIVE; CELL DIVISION; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTERS; DIFFUSION; ENERGY METABOLISM; ESTERIFICATION; HUMANS; KINETICS; LIPOPROTEINS, HDL; POTASSIUM CYANIDE; TANGIER DISEASE; TEMPERATURE;

EID: 0030798659     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Phillips, M. C., W. J. Johnson, and G. H. Rothblat. 1987. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906: 223-276.
2. Badimon, J. J., L. Badimon, A. Galvez, R. Dische, and V. Fuster. 1989. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab. Invest. 60: 455-461.
3. Badimon, J. J., L. Badimon, and V. Fuster. 1990. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85: 1234-1241.
4. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
5. Paszty, C., N. Maeda, J. Verstuyft, and E. M. Rubin. 1994. Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903.
6. Johnson, W. J., F. H. Mahlberg, G. H. Rothblat, and M. C. Philips. 1991. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta. 1085: 273-298.
7. Rothblat, G. H., F. H. Mahlberg, W. J. Johnson, and M. C. Phillips. 1992. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33: 1091-1097.
8. Karlin, J. B., W. J. Johnson, C. R. Benedict, G. K. Chacko, M. C. Phillips, and G. H. Rothblat. 1987. Cholesterol flux between cells and high density lipoprotein: lack of relationship to specific binding of the lipoprotein to the cell surface. J. Biol. Chem. 262: 12557-12564.
9. Mahlberg, F. H., and G. H. Rothblat. 1992. Cellular cholesterol efflux: role of cell membrane kinetic pools and interaction with apolipoproteins A-I, A-II and Cs. J. Biol. Chem. 267: 4541-4550.
10. Rothblat, G. H., and M. C. Phillips. 1982. Mechanism of cellular cholesterol efflux from cells. Effects of acceptor structure and composition. J. Biol. Chem. 257: 4775-4782.
11. Bartholow, L. G, and R. P. Geyer. 1982. Sterol efflux from mammalian cells induced by human serum albuminphospholipid complexes: dependence on phospholipid acyl chain length, degree of saturation, and net charge. J. Biol. Chem. 257: 3126-3130.
12. Hara, H., and S. Yokoyama. 1992. Role of apolipoproteins in cholesterol efflux from macrophages to lipid micro-emulsion: proposal of a putative model for the pre-beta high density lipoprotein pathway. Biochemistry. 31: 2040-2046.
13. Ho, Y. K., M. S. Brown, and J. L. Goldstein. 1980. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoproteins and other agents. J. Lipid Res. 21: 391-398.
14. Mendez, A. J., G. M. Anantharamaiah, J. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in cellular cholesterol clearance. J. Clin. Invest. 94: 1698-1705.
15. Mendez, A. J., J. F. Oram, and E. L. Bierman. 1991. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266: 10104-10111.
16. Therit, N., C. Delbart, G. Aguie, J-C. Fruchart, G. Vassaux, and G. Ailhaud, 1990. HDL3 stimulates protein kinase C in brain capillary endothelial cells. Biochem. Biophys. Res. Commun. 173: 1361-1368.
17. Slotte, J. P., J. F. Oram, and E. L. Bierman. 1986. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J. Biol. Chem. 262: 12904-12907.
18. Oram, J. F., A. J. Mendez, J. P. Slotte, and T. J. Johnson. 1991. High density lipoprotein apolipoproteins mediated removal of sterol from intracellular pools but not from the plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11: 403-414.
19. Lee, M., L. K. Lindstedt, and P. T. Kovanen. 1992. Mast cell-mediated inhibition of reverse cholesterol transport. Arterioscler. Thromb. 12: 1329-1335.
20. Mendez, A. J., and J. F. Oram. 1997. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux. Biochim. Biophys. Acta. In press.
21. Leblond, L., and Y. L. Marcel. 1991. The amphipathic alpha-helical repeats of apolipoprotein A-I are responsible for binding of high density lipoproteins to HepG2 cells. J. Biol. Chem. 266: 6058-6067.
22. Banka, C. L., A. S. Black, and L. K. Curtiss. 1994. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269: 10288-10297.
23. Luchoomun, J., N. Therit, V. Clavey, P. Duchateau, M. Roseneu, R. Brasseur, P. Denefle, J-C. Fruchart, and G. R. Castro. 1994. Structural domain of apoA-I involved in its interaction with cells. Biochim. Biophys. Acta. 1212: 319-326.
24. Bernard, D. W., A. Rodriguez, G. H. Rothblat, and J. M. Glick. 1991. cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J774 macrophages. J. Biol. Chem. 266: 710-716.
25. Hokland, B. M., J. P. Slotte, E. L. Bierman, and J. F. Oram. 1994. Cyclic AMP stimulates efflux of intracellular cholesterol from cholesterol-loaded cells. J. Biol. Chem. 268: 25343-25349.
26. Walter, M., H. Reinecke, U. Gerdes, I-R. Nofer, G Höbbel, U. Seedorf, and G. Assman. 1996. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J. Clin. Invest. 98: 2315-2323.
27. Smith, J. D., M. Miyata, M. Ginsberg, C. Grigaux, E. Shmookler, and A. S. Plump. 1996. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271: 30647-30655.
28. Graham, D. L., and J. F. Oram. 1987. Identification and characterization of a high density lipoprotein-binding protein in cell membrane by ligand blotting. J. Biol. Chem. 262: 7439-7442.
29. Tozuka, M., and N. H. Fidge. 1989. Purification and characterization of two high-density-lipoprotein binding proteins from rat and human liver. Biochem. J. 261: 239-244.
30. Barbaras, R., P. Puchois, J-C. Fruchart, A. Pradines-Figuères, and G. Ailhaud. 1990. Purification of an apolipoprotein A binding protein from mouse adipose cells. Biochem. J. 269: 767-773.
31. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages. J. Biol. Chem. 266: 3080-3086.
32. Hara, H., H. Hara, A. Komaba, and S. Yokoyama. 1992. Alpha-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 27: 302-304.
33. Bielicki, J. K., W. J. Johnson, R. B. Weinberg, J. M. Glick, and G. H. Rothblat. 1992. Efflux of lipid from fibroblasts to apolipoproteins; dependence on elevated levels of cellular unesterified cholesterol. J. Lipid. Res. 33: 1699-1709.
34. Mendez, A. J., G. M. Anantharamaiah, J. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in cellular cholesterol clearance. J. Clin. Invest. 94: 1698-1705.
35. Savion, N., and S. Kotev-Emeth. 1993. Role of apolipoproteins A-I, A-II and C-I in cholesterol efflux from endothelial and smooth muscle cells. Eur. Heart J. 14: 930-935.
36. Mendez, A. J., and L. Uint. 1996. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J. Lipid Res. 37: 2510-2524.
37. Francis, G. A., R. H. Knopp, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96: 78-87.
38. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
39. Forte, T. M., R. Goth-Goldstein, R. W. Nordhauser, and M. R. McCall. 1993. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J. Lipid Res. 34: 317-324.
40. Li, Q., A. Komaba, and S. Yokoyama. 1993. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry. 32: 4597-4603.
41. Dory, L., L. M. Boquet, R. L. Hamilton, C. H. Sloop, and P. S. Roheim. 1985. Heterogeneity of dog interstitial fluid (peripheral lymph) high density lipoproteins: implications for a role in reverse cholesterol transport. J. Lipid Res. 26: 519-527.
42. Neary, R. H., and E. Gowland. 1987. Stability of free apolipoprotein A-I concentration in serum and its measurements in normal and hyperlipidemic subjects. Clin. Chem. 33: 1163-1169.
43. Asztalos, B. F., and P. S. Roheim. 1995. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler. Thromb. Vasc. Biol. 5: 1419-1423.
44. Oram, J. F., and S. Yokoyama. 1996. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37: 2473-2491.
45. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
46. Mendez, A. J. 1995. Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol efflux from cholesterol-enriched cells. Implications for intracellular cholesterol transport. J. Biol. Chem. 270: 5891-5900.
47. Rogler, G., B. Trümbach, B. Klima, K. J. Lackner, and G. Schmitz. 1995. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler: Thromb. Vasc. Biol. 15: 683-690.
48. Mendez, A. J., J. L. He, H. S. Huang, S. R. Wen, and S. L. Hsia. 1988. Interaction of rabbit lipoproteins and red blood cells with liposomes of egg yolk phospholipids. Lipids. 23: 961-967.
49. Lowry, O. H., N. Rosebrough, A. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol re-agent. J. Biol. Chem. 193: 265-275.
50. Artiss, J. D., and B. Zak. 1980. A sensitive reaction for dilute cholesterol determinations. Microchem. J. 25: 535-542.
51. Heider, J. G., and R. Boyett. 1978. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19: 514-518.
52. Oram, J. F. 1986. Receptor-mediated transport of cholesterol between cultured cells and high density lipoproteins. Methods Enzymol. 129: 645-659.
53. Backer, J. M., and E. A. Dawidowicz. 1981. Transmembrane movement of cholesterol in small unilamellar vesicles as detected by cholesterol oxidase. J. Biol. Chem. 256: 568-588.
54. Lange, Y., M. H. Swaisgood, B. V. Ramos, and T. L. Steck. 1989. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J. Biol. Chem. 264: 3786-3793.
55. Kilsdonk, E. P. C., P. G. Yancey, G. W. Stoudt, F. W. Bangerter, W. J. Johnson, M. C. Phillips, and G. H. Rothblat. 1995. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270: 17250-17256.
56. Komaba, A., Q. Li, H. Hara, and S. Yokoyama. 1992. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol J. Biol. Chem. 267: 17560-17566.
57. Li, Q., H., Czarnecka, and S. Yokoyama. 1995. Involvement of a cellular surface faclor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1259: 227-234.
58. Phillips, M. C., L. R. McLean, G. W. Stoudt, and G. H. Rothblat. 1980. Mechanism of cholesterol efflux from cells. Atherosclerosis. 36: 409-422.
59. Tartakoff, A. M. 1986. Temperature and energy dependence of secretory protein transport in the exocrine pancreas. EMBO J. 5: 1477-1482.
60. Saraste J., G. E. Palade, and M. G. Farquhar. 1986. Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells. Proc. Natl. Acad. Sci. USA. 83: 6425-6429.
61. Tsujita, M., and S. Yokoyama. 1996. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol. Biochemistry. 35: 13011-13020.
62. Francis, G. A., J. F. Oram, J. W. Heinecke, and E. L. Bierman. 1996. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry. 35: 15188-15197.
63. Lehninger, A. L. 1972. Bioenergetics: The Molecular Basis of Biological Transformations. 2nd Edition. W. A. Benjamin, Menlo Park, CA. 197-201.